Consumer

North America Pet Grooming Services Market Report 2021-2027 - ResearchAndMarkets.com

Tuesday, July 27, 2021 - 12:10pm

The "North America Pet Grooming Services Market By Type (Bathing & Brushing, Nail Trimming, and Other Types), By Application (Commercial and Household), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America Pet Grooming Services Market By Type (Bathing & Brushing, Nail Trimming, and Other Types), By Application (Commercial and Household), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The growing awareness among pet owners regarding pet grooming and their health is one of the factors fuelling the market growth.
  • In addition, the high demand for organic and natural products for pet grooming by pet owners can also support the regional market.
  • Thus, using non-toxic, natural, eco-friendly, and organic grooming products for various grooming services like massages, bathing, and ear & eye cleaning is expected to propel the regional U.S pet grooming services market over the forecast period.

TCN Consumer Survey Finds Americans Overwhelmingly Prefer to Interact with a Live Person When Dealing with Customer Service Reps

Tuesday, July 27, 2021 - 12:05pm

Americans are willing to wait on hold, but not for long. When calling a company’s customer service department, Americans said they are willing to wait on hold for six minutes, but the actual wait time on average is three times longer. One-third (34%) said they’re willing to wait on hold between five to seven minutes, an average of six minutes overall, with women (15%) twice as likely as men (8%) to be willing to wait 10 minutes or longer. However, the average actual wait time on hold is 17.4 minutes, with 2 in 3 (62%) saying they’ve waited on hold longer than 10 minutes and nearly one-quarter (23%) saying they’ve waited on hold for 30 minutes or longer. Women are more patient -- they’re twice as likely (31%) as men (13%) to wait on hold more than 30 minutes.

Key Points: 
  • The national survey, conducted by OnePoll and commissioned by TCN, reveals Americans overwhelmingly prefer to interact with a live person when dealing with customer service centers.
  • The survey also finds companies that prioritize good customer service are likely to be rewarded by consumers with increased brand loyalty and positive online reviews.
  • In the survey, consumers said they are likely to reward companies with good customer service with increased brand loyalty and positive online reviews.
  • To view the full survey results, download TCNs ebook, Understanding the Modern Consumer: 2021 Consumer Insights About Customer Service, at: https://go.tcn.com/customer-service-survey-results-2021 .

Quotient Survey Reveals 84% of Dog and Cat Owners (18+) Believe Pet Food Will Be the Biggest Cost of Ownership Over the Next Year, Some Will Even Cook for Their Furry Friends

Tuesday, July 27, 2021 - 1:00pm

In a survey of over 1,000 US cat and dog owners aged 18+, 33% noted that they adopted a pet during the pandemic.

Key Points: 
  • In a survey of over 1,000 US cat and dog owners aged 18+, 33% noted that they adopted a pet during the pandemic.
  • The survey shows that of the people who adopted pets during the pandemic, 52% were male and 48% were female.
  • 44% of dog and cat owners are also planning to pamper their pooches and kitties with the intent to purchase treats.
  • When asked where they usually shop for their dog and/or cat, pet superstores received the greatest number of responses (48%).

lululab Leads K-Beauty Advancement With AI-Based Skincare Solution

Tuesday, July 27, 2021 - 1:00pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210727005069/en/
    LUMINI is an AI-based skin analysis solution developed by lululab.
  • The LUMINI is a convenient and hygienic solution to measure and diagnose skin conditions and even provide customized skincare services using artificial intelligence and big data technologies.
  • Based on this function, lululab plans to expand the B2B supply of LUMINI through collaboration with dermatology, cosmetic surgery clinics, cosmetics stores and skincare salons.
  • lululab is shaping up the vision to connect all the beauty entities with skin data, said lululab CEO Yongjoon Choe.

CareView Communications Executes Expansion Hospital Agreement With Clovis Community Medical Center

Tuesday, July 27, 2021 - 1:00pm

CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, today announced the expansion of a hospital agreement with Clovis Community Medical Center in Clovis, California (Clovis Community).

Key Points: 
  • CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, today announced the expansion of a hospital agreement with Clovis Community Medical Center in Clovis, California (Clovis Community).
  • Clovis Community has utilized CareViews Patient Safety System with positive outcomes since 2016 and includes CareView as a part of the hospitals expansion.
  • With the use of CareViews innovative system, hospitals can be confident in their efforts of increasing quality care along with patient safety.
  • We look forward to expanding our commitment to helping Clovis Community Medical Center provide their patients with enhanced services using our latest equipment, particularly their at-risk patients who require more observation.

U.S. In-Vitro Fertilization Market is Expected to Grow at a CAGR of 5.45% During the Period 2021-2026. - ResearchAndMarkets.com

Tuesday, July 27, 2021 - 9:54am

The "U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. In-vitro Fertilization Market Report
    The U.S. in-vitro fertilization market by revenue is expected to grow at a CAGR of 5.45% during the period 2021-2026.
  • The following factors are likely to contribute to the growth of the U.S. in-vitro fertilization market during the forecast period:
    The study considers the present scenario of the U.S. In-vitro fertilization market and its market dynamics for the period 2020-2026.
  • 4. Who are the key players in the US in-vitro fertilization market?

Female Infertility Treatment Drugs Market by Therapy, Route of Administration, Distribution Channel, and Region - Global Size, Share, Outlook, and Opportunity Analysis, 2021-2028 - ResearchAndMarkets.com

Tuesday, July 27, 2021 - 9:52am

The "Female Infertility Treatment Drugs Market, by Therapy, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Female Infertility Treatment Drugs Market, by Therapy, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Market players are focusing on various growth strategies such as agreements, partnerships, and collaborations to accelerate the development of drugs for infertility treatment, which is expected to boost growth of the global female infertility treatment drugs market over the forecast period.
  • For instance, in January 2020, Bayer AG announced the expansion of their partnership with Evotec SE, a biotechnology company focusing on women health, with a new five-year, multi-target collaboration to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (PCOS), which is one of the causes of infertility in females.
  • Moreover, in January 2019, Ferring Pharmaceuticals, a biopharmaceutical company entered into an exclusive agreement with Sun Pharmaceutical Industries Ltd., an India-based multinational pharmaceutical company to acquire the U.S. commercialization rights for a generic version of Ganirelix Acetate injection which is used for treatment of female infertility.

NTT DATA UK Announces New Partnership with myGwork

Tuesday, July 27, 2021 - 9:00am

NTT DATA UK has announced a new partnership with myGwork as part of its ongoing D&I work.

Key Points: 
  • NTT DATA UK has announced a new partnership with myGwork as part of its ongoing D&I work.
  • As part of the partnership, the networking platform will feature news, jobs, and contributed articles from NTT DATA UK.
  • The partnership with myGwork is part of NTT DATA UK's work as a company that actively supports the LGBTQ+ community.
  • Through the partnership, NTT DATA UK hopes to build community and awareness around the benefits of nurturing an inclusive workforce.

Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor

Tuesday, July 27, 2021 - 6:00am

Ebopiprant is an investigational, orally active, selective prostaglandin F2 (PGF2) receptor antagonist being evaluated as a potential treatment for preterm labor by reducing inflammation and uterine contractions.

Key Points: 
  • Ebopiprant is an investigational, orally active, selective prostaglandin F2 (PGF2) receptor antagonist being evaluated as a potential treatment for preterm labor by reducing inflammation and uterine contractions.
  • Brian OCallaghan, CEO of ObsEva, commented, "Organon is the ideal partner for the development and commercialization of ebopiprant and we see this agreement as an important step in advancing this investigational agent.
  • Under the terms of the agreement, Organon will gain exclusive worldwide rights to develop and commercialize ebopiprant.
  • In November 2020, ObsEva announced positive results from PROLONG, the Phase 2a proof-of-concept, randomized, double-blind, placebo-controlled trial of ebopiprant in preterm labor.

Genetic Technologies Rapidly Accelerating Commercialization Plans

Monday, July 26, 2021 - 1:25pm

The Company has previously outlined its key avenues for commercialization which currently include the consumer-initiated online sales and marketing platform (CIT) available in Australia and the US.

Key Points: 
  • The Company has previously outlined its key avenues for commercialization which currently include the consumer-initiated online sales and marketing platform (CIT) available in Australia and the US.
  • Additionally, GTG is engaging in business to business (B2B) sales via medical professionals and now has distribution coverage of the Australian and US markets.
  • The Multitest will leverage the foundational IP granted under US Patent 7,127,355 Methods for Genetic Analysis.
  • The increased sample numbers have enabled separation into test and validation datasets, a key requirement for commercialization.